These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33202527)

  • 1. Influence of Indomethacin on Steroid Metabolism: Endocrine Disruption and Confounding Effects in Urinary Steroid Profiling of Anti-Doping Analyses.
    Stoll A; Iannone M; De Gregorio G; Molaioni F; de la Torre X; Botrè F; Parr MK
    Metabolites; 2020 Nov; 10(11):. PubMed ID: 33202527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Pain Killers on the Urinary Anabolic Steroid Profile.
    Stoll A; Iannone M; De Gregorio G; de la Torre X; Molaioni F; Botrè F; Kristina Parr M
    J Anal Toxicol; 2020 Dec; 44(8):871-879. PubMed ID: 32390041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of athletes` hyperhydration on the urinary 'steroid profile' markers in doping control analysis.
    Athanasiadou I; Kraiem S; Al-Sowaidi S; Al-Mohammed H; Dbes N; Al-Yazedi S; Samsam W; Mohamed-Ali V; Dokoumetzidis A; Alsayrafi M; Valsami G; Georgakopoulos C
    Drug Test Anal; 2018 Sep; 10(9):1458-1468. PubMed ID: 29745045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting Doping in Elite Sports: Blood for All Tests!
    Faiss R; Saugy J; Saugy M
    Front Sports Act Living; 2019; 1():30. PubMed ID: 33344954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
    Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
    Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical discrimination of steroid profiles in doping control with support vector machines.
    Van Renterghem P; Sottas PE; Saugy M; Van Eenoo P
    Anal Chim Acta; 2013 Mar; 768():41-8. PubMed ID: 23473248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous steroid profiling in the athlete biological passport.
    Sottas PE; Saugy M; Saudan C
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):59-73, viii-ix. PubMed ID: 20122450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.
    Helmlin HJ; Mürner A; Steiner S; Kamber M; Weber C; Geyer H; Guddat S; Schänzer W; Thevis M
    Forensic Sci Int; 2016 Oct; 267():166-172. PubMed ID: 27611956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes.
    Van Renterghem P; Van Eenoo P; Geyer H; Schänzer W; Delbeke FT
    Steroids; 2010 Feb; 75(2):154-63. PubMed ID: 19962394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of musk administration on the doping test.
    He Y; Wang J; Liu X; Xu Y; He Z
    Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemometric evaluation of urinary steroid profiles in doping control.
    Norli HR; Esbensen K; Westad F; Birkeland KI; Hemmersbach P
    J Steroid Biochem Mol Biol; 1995 Jul; 54(1-2):83-8. PubMed ID: 7632620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS.
    Aguilera R; Chapman TE; Pereira H; Oliveira GC; Illanes RP; Fernandes TF; Azevedo DA; Neto FA
    J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):107-14. PubMed ID: 19428237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
    Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
    Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of androgenic-anabolic steroids in athletes.
    Hartgens F; Kuipers H
    Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
    Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
    Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes.
    Bauman DR; Rudnick SI; Szewczuk LM; Jin Y; Gopishetty S; Penning TM
    Mol Pharmacol; 2005 Jan; 67(1):60-8. PubMed ID: 15475569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.